Authors:
MEINKE PT
ARISON B
CULBERSON JC
FISHER MH
MROZIK H
Citation: Pt. Meinke et al., SYNTHESIS OF 1,19-AZA-1,19-DEOXY-AVERMECTIN B-1A - THE FIRST AVERMECTIN MACROLACTAM, Journal of organic chemistry, 63(8), 1998, pp. 2591-2596
Authors:
OLSEN DB
CARROLL SS
CULBERSON JC
SHAFER JA
KUO LC
Citation: Db. Olsen et al., EFFECT OF TEMPLATE SECONDARY STRUCTURE ON THE INHIBITION OF HIV-1 REVERSE-TRANSCRIPTASE BY A PYRIDINONE NONNUCLEOSIDE INHIBITOR, Nucleic acids research, 22(8), 1994, pp. 1437-1443
Authors:
WILLIAMS PD
ANDERSON PS
BALL RG
BOCK MG
CARROLL L
CHIU SHL
CLINESCHMIDT BV
CULBERSON JC
ERB JM
EVANS BE
FITZPATRICK SL
FREIDINGER RM
KAUFMAN MJ
LUNDELL GF
MURPHY JS
PAWLUCZYK JM
PERLOW DS
PETTIBONE DJ
PITZENBERGER SM
THOMPSON KL
VEBER DF
Citation: Pd. Williams et al., )-YL)METHYL)SULFONYL)-4-(2-METHYLPHENYL)PIPERAZINE (L-368,899) - AN ORALLY BIOAVAILABLE, NONPEPTIDE OXYTOCIN ANTAGONIST WITH POTENTIAL UTILITY FOR MANAGING PRETERM LABOR, Journal of medicinal chemistry, 37(5), 1994, pp. 565-571
Authors:
GHOSH AK
THOMPSON WJ
FITZGERALD PMD
CULBERSON JC
AXEL MG
MCKEE SP
HUFF JR
ANDERSON PS
Citation: Ak. Ghosh et al., STRUCTURE-BASED DESIGN OF HIV-1 PROTEASE INHIBITORS - REPLACEMENT OF 2 AMIDES AND A 10-PI-AROMATIC SYSTEM BY A FUSED BIS-TETRAHYDROFURAN, Journal of medicinal chemistry, 37(16), 1994, pp. 2506-2508
Authors:
SARDANA VV
SCHLABACH AJ
GRAHAM P
BUSH BL
CONDRA JH
CULBERSON JC
GOTLIB L
GRAHAM DJ
KOHL NE
LAFEMINA RL
SCHNEIDER CL
WOLANSKI BS
WOLFGANG JA
EMINI EA
Citation: Vv. Sardana et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS - EVALUATION OF RESISTANCE ENGENDERED BY AMINO-ACID SUBSTITUTIONS IN THE ENZYMES SUBSTRATE-BINDING SITE, Biochemistry, 33(8), 1994, pp. 2004-2010